Roche Pharma Central America & the Caribbean
Alvaro Soto-Monge is from Costa Rica and has worked for the biopharmaceutical company Roche for more than 28 years. Currently, he is the general manager for Central America and the Caribbean (CAC), where he leads the company’s commitment to be a partner in the evolution of healthcare ecosystems, driving the transformation of Roche’s portfolio to ensure that innovation reaches patients as soon as possible, and positioning the company as a benchmark for sustainability in the pharmaceutical industry.
He is a visionary and catalyst leader, who inspires purpose-driven teams to think innovatively and achieve new goals for the well-being of patients.
His extensive experience at Roche has allowed him to assume responsibilities and develop the necessary skills to work in markets with different situations and needs.
In his first steps at the company, he worked in the treasury and controller area. Later, he was a corporate auditor at Roche’s headquarters in Basel, Switzerland. From this position, he implemented several projects for Latin America. Years later, he took on a new professional challenge as Finance and Administration Director in Belgium. After this role, he returned to the American continent as CFO for Roche Mexico; in this same country, he later assumed the Oncology Business Unit.
This innate leader of the pharmaceutical industry decided to return, 10 years ago, to Costa Rica and assume the general management for Central America and the Caribbean. Afterwards, his vast capacity and knowledge allowed him to serve – during four years - as president of the Roche sub region for Latin America, where he oversaw operations in Central America and the Caribbean, Ecuador, Chile, Peru, Uruguay, Bolivia, Paraguay and Venezuela.
His professional motivation is to be part of a multidisciplinary, dynamic team that is willing to take risks aimed at making innovation available to improve the quality of life of patients in the region. Working in a company focused on innovation and the patient, presents a unique opportunity to work in areas such as cancer, hematology, multiple sclerosis and hemophilia, among others.
He currently holds the presidency of the Central American Federation of Pharmaceutical Laboratories (Fedefarma), which represents 18 pharmaceutical research and development companies present in the region.